Perhaps the best described disease associated with reduced cellular CoA-SH levels is pantothenate kinase-associated neurodegeneration (PKAN), also known as Hallervorden–Spatz disease, an autosomal recessive inherited disease caused by a mutation in the PANK2 gene. This evidence concerns the gene PANK2 and pantothenate kinase-associated neurodegeneration.